Literature DB >> 27166862

Correction: Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.

Yunjeong Kim, Hongwei Liu, Anushka C Galasiti Kankanamalage, Sahani Weerasekara, Duy H Hua, William C Groutas, Kyeong-Ok Chang, Niels C Pedersen.   

Abstract

[This corrects the article DOI: 10.1371/journal.ppat.1005531.].

Entities:  

Year:  2016        PMID: 27166862      PMCID: PMC4864313          DOI: 10.1371/journal.ppat.1005650

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


There are errors in the Funding section. The correct funding information is as follows: The in vitro assays and drug synthesis were supported by NIH grant R01AI109039 (http://www.nih.gov, PI: KC) and Morris Animal Foundation D14FE-012 (http://www.morrisanimalfoundation.org, PI: YK). The PK and safety studies were supported by Winn Feline Foundation Miller Fund MT13-006 (http://www.winnfelinefoundation.org. PI: NCP) and the Center for Companion Animal Health (http://www.vetmed.ucdavis.edu/ccah/. PI: NCP). The in vivo efficacy study was supported by the Center for Companion Animal Health (http://www.vetmed.ucdavis.edu/ccah/. PI: NCP) and the Kansas State University Global Food Systems program (GPRE002839) (PI: YK). Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
  1 in total

1.  Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.

Authors:  Yunjeong Kim; Hongwei Liu; Anushka C Galasiti Kankanamalage; Sahani Weerasekara; Duy H Hua; William C Groutas; Kyeong-Ok Chang; Niels C Pedersen
Journal:  PLoS Pathog       Date:  2016-03-30       Impact factor: 6.823

  1 in total
  12 in total

Review 1.  Minireview of progress in the structural study of SARS-CoV-2 proteins.

Authors:  Guoliang Zhu; Chunmei Zhu; Yun Zhu; Fei Sun
Journal:  Curr Res Microb Sci       Date:  2020-06-29

Review 2.  Recent discovery and development of inhibitors targeting coronaviruses.

Authors:  Thanigaimalai Pillaiyar; Sangeetha Meenakshisundaram; Manoj Manickam
Journal:  Drug Discov Today       Date:  2020-01-30       Impact factor: 7.851

3.  A retrospective study of clinical and laboratory features and treatment on cats highly suspected of feline infectious peritonitis in Wuhan, China.

Authors:  Yiya Yin; Ting Li; Chaohao Wang; Xiaoya Liu; Hehao Ouyang; Wanfeng Ji; Jiahao Liu; Xueyu Liao; Junyi Li; Changmin Hu
Journal:  Sci Rep       Date:  2021-03-04       Impact factor: 4.379

4.  Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element.

Authors:  Anushka C Galasiti Kankanamalage; Yunjeong Kim; Vishnu C Damalanka; Athri D Rathnayake; Anthony R Fehr; Nurjahan Mehzabeen; Kevin P Battaile; Scott Lovell; Gerald H Lushington; Stanley Perlman; Kyeong-Ok Chang; William C Groutas
Journal:  Eur J Med Chem       Date:  2018-03-06       Impact factor: 6.514

5.  Characterization of amino acid substitutions in feline coronavirus 3C-like protease from a cat with feline infectious peritonitis treated with a protease inhibitor.

Authors:  Krishani Dinali Perera; Athri D Rathnayake; Hongwei Liu; Niels C Pedersen; William C Groutas; Kyeong-Ok Chang; Yunjeong Kim
Journal:  Vet Microbiol       Date:  2019-08-23       Impact factor: 3.246

Review 6.  Bioactive natural compounds against human coronaviruses: a review and perspective.

Authors:  Yanfang Xian; Juan Zhang; Zhaoxiang Bian; Hua Zhou; Zhenbiao Zhang; Zhixiu Lin; Hongxi Xu
Journal:  Acta Pharm Sin B       Date:  2020-06-08       Impact factor: 11.413

Review 7.  Race to arsenal COVID-19 therapeutics: Current alarming status and future directions.

Authors:  Ankit Kumar Dubey; Aakansha Singh; Shardendu Prakash; Manoj Kumar; Ashok K Singh
Journal:  Chem Biol Interact       Date:  2020-10-27       Impact factor: 5.192

8.  Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry.

Authors:  Zachary A Gurard-Levin; Cheng Liu; Andreas Jekle; Ruchika Jaisinghani; Suping Ren; Koen Vandyck; Dirk Jochmans; Pieter Leyssen; Johan Neyts; Lawrence M Blatt; Leonid Beigelman; Julian A Symons; Pierre Raboisson; Michael D Scholle; Jerome Deval
Journal:  Antiviral Res       Date:  2020-09-05       Impact factor: 5.970

9.  Potential SARS-CoV-2 3CLpro inhibitors from chromene, flavonoid and hydroxamic acid compound based on FRET assay, docking and pharmacophore studies.

Authors:  Maywan Hariono; Pandu Hariyono; Rini Dwiastuti; Wahyuning Setyani; Muhammad Yusuf; Nurul Salin; Habibah Wahab
Journal:  Results Chem       Date:  2021-09-20

Review 10.  Feline Coronavirus Antivirals: A Review.

Authors:  Manon Delaplace; Hélène Huet; Adèle Gambino; Sophie Le Poder
Journal:  Pathogens       Date:  2021-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.